Contract with Customer, Liability, Current of Avid Bioservices, Inc. from 30 Apr 2018 to 31 Oct 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Avid Bioservices, Inc. quarterly Contract with Customer, Liability, Current in USD history and change rate from 30 Apr 2018 to 31 Oct 2024.
  • Avid Bioservices, Inc. Contract with Customer, Liability, Current for the quarter ending 31 Oct 2024 was $51,671,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

Avid Bioservices, Inc. Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $51,671,000 +$5,234,000 +11% 31 Oct 2024 10-Q 10 Dec 2024 2025 Q2
Q2 2024 $37,659,000 +$4,640,000 +14% 31 Jul 2024 10-Q 09 Sep 2024 2025 Q1
Q1 2024 $39,887,000 +$2,535,000 +6.8% 30 Apr 2024 10-Q 10 Dec 2024 2025 Q2
Q4 2023 $52,945,000 +$15,195,000 +40% 31 Jan 2024 10-Q 24 Apr 2024 2024 Q3
Q3 2023 $46,437,000 -$2,009,000 -4.1% 31 Oct 2023 10-Q/A 24 Apr 2024 2024 Q2
Q2 2023 $33,019,000 -$19,756,000 -37% 31 Jul 2023 10-Q/A 24 Apr 2024 2024 Q1
Q1 2023 $37,352,000 -$16,446,000 -31% 30 Apr 2023 10-K 02 Jul 2024 2024 FY
Q4 2022 $37,750,000 -$21,241,000 -36% 31 Jan 2023 10-K/A 24 Apr 2024 2023 FY
Q3 2022 $48,446,000 -$3,419,000 -6.6% 31 Oct 2022 10-K/A 24 Apr 2024 2023 FY
Q2 2022 $52,775,000 +$6,513,000 +14% 31 Jul 2022 10-K/A 24 Apr 2024 2023 FY
Q1 2022 $53,798,000 +$3,029,000 +6% 30 Apr 2022 10-K/A 24 Apr 2024 2023 FY
Q4 2021 $58,991,000 +$11,284,000 +24% 31 Jan 2022 10-Q 08 Mar 2022 2022 Q3
Q3 2021 $51,865,000 +$20,415,000 +65% 31 Oct 2021 10-Q 07 Dec 2021 2022 Q2
Q2 2021 $46,262,000 +$19,139,000 +71% 31 Jul 2021 10-Q 08 Sep 2021 2021 Q1
Q1 2021 $50,769,000 +$21,649,000 +74% 30 Apr 2021 10-K 29 Jun 2022 2022 FY
Q4 2020 $47,707,000 +$21,352,000 +81% 31 Jan 2021 10-Q 08 Mar 2021 2021 Q3
Q3 2020 $31,450,000 +$9,251,000 +42% 31 Oct 2020 10-Q 02 Dec 2020 2021 Q2
Q2 2020 $27,123,000 +$9,019,000 +50% 31 Jul 2020 10-Q 01 Sep 2020 2021 Q1
Q1 2020 $29,120,000 +$14,469,000 +99% 30 Apr 2020 10-K 29 Jun 2021 2021 FY
Q4 2019 $26,355,000 +$11,735,000 +80% 31 Jan 2020 10-Q 10 Mar 2020 2020 Q3
Q3 2019 $22,199,000 +$4,892,000 +28% 31 Oct 2019 10-Q 09 Dec 2019 2020 Q2
Q2 2019 $18,104,000 +$110,000 +0.61% 31 Jul 2019 10-Q 05 Sep 2019 2020 Q1
Q1 2019 $14,651,000 -$13,284,000 -48% 30 Apr 2019 10-K 30 Jun 2020 2020 FY
Q4 2018 $14,620,000 31 Jan 2019 10-Q 11 Mar 2019 2019 Q3
Q3 2018 $17,307,000 31 Oct 2018 10-Q 10 Dec 2018 2019 Q2
Q2 2018 $17,994,000 31 Jul 2018 10-Q 10 Sep 2018 2019 Q1
Q1 2018 $27,935,000 30 Apr 2018 10-K 27 Jun 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.